Key facts
- This page summarizes Ellen de Brabander's Form 4 filing for Elanco Animal Health Inc (ELAN).
- 2 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 21 Feb 2025, 18:13.
Ellen de Brabander - 19 Feb 2025 Form 4 Insider Report for Elanco Animal Health Inc (ELAN)
- Reporting relationship
- Executive Vice President of Innovation and Regulatory Affairs
- Issuer ticker
- ELAN
- Reported as of
- 19 Feb 2025
- Net transaction value
- -$785,856
- SEC form
- 4
- Accepted by SEC
- 21 Feb 2025, 18:13:08 UTC
- Prior SEC filing
- 03 Jan 2025
- Next SEC filing
- 04 Mar 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ Amy C. Seidel, as Attorney-in-Fact for Ellen de Brabander
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Ellen de Brabander filed Form 4 for Elanco Animal Health Inc (ELAN) on 21 Feb 2025.
Change
- Previous filing in this sequence was filed on 03 Jan 2025.
- Current net transaction value: -$785,856.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
ELAN
transaction
Common Stock
Award
- Transaction value
- $0
- Shares
- +141,244
- Change %
- +123%
- Price
- $0.000000
- Shares after
- 256,130
- Date
- 19 Feb 2025
- Ownership
- Direct
ELAN
transaction
Common Stock
Tax liability
- Transaction value
- $785,856
- Shares
- -69,916
- Change %
- -27%
- Price
- $11.24
- Shares after
- 186,214
- Date
- 19 Feb 2025
- Ownership
- Direct
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
SEC remarks
Executive Vice President of Innovation and Regulatory Affairs